Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Honey in Orabase is a topical mucoadhesive formulation used primarily for the management of oral mucosal lesions, such as radiation-induced oral mucositis and recurrent aphthous stomatitis. This combination leverages the therapeutic properties of honey—including its antibacterial, anti-inflammatory, and antioxidant effects—with the adhesive properties of Orabase, a protective dental paste. Honey promotes wound healing by maintaining a moist environment, reducing inflammation through the inhibition of prostaglandins, and providing a physical barrier against infection. Orabase, typically composed of gelatin, pectin, and sodium carboxymethylcellulose in a plasticized hydrocarbon gel, ensures prolonged contact time of the honey with the moist oral mucosa, enhancing its clinical efficacy compared to honey alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on honey in Orabase.